Insights Ahead: Evaxion Biotech's Quarterly Earnings

Evaxion Biotech EVAX will release its quarterly earnings report on Thursday, 2025-08-14. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Evaxion Biotech to report an earnings per share (EPS) of $-0.55.

Evaxion Biotech bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Earnings History Snapshot

During the last quarter, the company reported an EPS beat by $0.69, leading to a 11.44% increase in the share price on the subsequent day.

Here's a look at Evaxion Biotech's past performance and the resulting price change:

Stock Performance

Shares of Evaxion Biotech were trading at $2.89 as of August 12. Over the last 52-week period, shares are down 80.56%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Evaxion Biotech visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.